Active, Not Recruiting
Glutamatergic Modulation as a Treatment for Depressive Symptoms Among Patients With Post-acute Sequelae of COVID (PASC): A Pilot Trial
NCT05690503
- Conditions
- Behavior, Behavioral Symptoms, COVID-19, +24 more
- Locations
-
- New York State Psychiatric Institute New York, United States